Abstract
This paper explores the undertheorized relationship between organizational stigma and corporate reputation, specifically how legitimate accounts are constructed in CSR disclosures in order to enhance corporate reputation, when facing episodes of intense stigma. Following single case study method, we qualitatively examine fourteen CSR reports released by the leading pharmaceutical firm GSK during the period of 2002-2015. Then, we analyse the influence of three episodes of intense stigmatization faced by GSK – Paxil, Avandia and China bribery scandals – on the salience of various themes induced from CSR reports. Our findings suggest that increase in intensity of public stigmatization of a firm may have a positive influence on the variety of themes included in CSR disclosures, targeting various bases of legitimacy – regulatory, associational and moral, and increase in dominance of moral legitimacy claims, over time.
Original language | English |
---|---|
Title of host publication | Academy of Management Annual Meeting Proceedings |
Publisher | Academy of Management |
Volume | 18 |
DOIs | |
Publication status | Published - 1 Aug 2018 |
Event | 78th Annual Meeting of the Academy of Management: Improving Lives - Chicago, United States Duration: 10 Aug 2018 → 14 Aug 2018 Conference number: 78 https://connect.aom.org/aom2018/home |
Conference
Conference | 78th Annual Meeting of the Academy of Management |
---|---|
Abbreviated title | 2018 AOM Annual Meeting |
Country/Territory | United States |
City | Chicago |
Period | 10/08/18 → 14/08/18 |
Internet address |